Induction Chemotherapy Prior to Radio-immunotherapy in Head and Neck Cancer Stage III/IV - a Methodical Trial

NCT00502463 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

51

Enrollment

NETWORK

Sponsor class

Conditions

Head and Neck Cancer

Interventions

DRUG: Docetaxel
DRUG: Cisplatin
DRUG: 5-FU
RADIATION: Radiotherapy
DRUG: Cetuximab

Sponsor

Austrian South Oncology Group

Collaborators

[object Object]